<![CDATA[
What Is Chelation Therapy?
Chelation therapy is a medical treatment that uses specific binding agents — called chelators — to remove toxic heavy metals and excess minerals from the body. The word “chelation” comes from the Greek chele, meaning claw, reflecting how these agents grasp and hold metal ions, allowing them to be safely excreted through the kidneys.
Originally developed to treat acute heavy metal poisoning (lead, mercury, arsenic), chelation therapy has evolved into an important component of integrative medicine for patients with chronic low-level metal exposure, environmental toxicity, and conditions where metal burden contributes to disease.
At St. George Hospital (Klinik St. Georg) in Bad Aibling, Germany, chelation therapy has been part of our detoxification and integrative treatment programs for decades. Under the clinical leadership of Dr. Julian Douwes, we use chelation as part of comprehensive treatment plans for patients with chronic infections, cancer, cardiovascular disease, neurological conditions, and environmental illness — always guided by rigorous testing and individualized protocols.
The Major Chelating Agents
Different chelators have different affinities for different metals. The selection of the appropriate agent is a critical clinical decision.
EDTA (Ethylenediaminetetraacetic Acid)
EDTA is the most widely studied chelator and has been in clinical use since the 1950s.
- Primary targets: Lead, cadmium, and calcium (as a component of arterial plaque).
- Administration: Intravenous infusion, typically over 1–3 hours.
- Key applications: Lead poisoning, cardiovascular disease (atherosclerosis), and general heavy metal detoxification.
- Evidence: The TACT trial (Trial to Assess Chelation Therapy), a landmark NIH-funded randomized controlled trial, demonstrated that EDTA chelation therapy reduced cardiovascular events by 18% overall and by 41% in diabetic patients with prior heart attacks (Lamas et al., 2013).
DMSA (Dimercaptosuccinic Acid)
- Primary targets: Mercury, lead, arsenic, and cadmium.
- Administration: Oral capsules — one of the few effective oral chelators.
- Key applications: Mercury toxicity (including dental amalgam-related exposure), lead toxicity, and arsenic exposure.
- Advantages: Well-tolerated, can be administered at home, does not significantly deplete essential minerals at proper doses.
DMPS (2,3-Dimercapto-1-propanesulfonic Acid)
- Primary targets: Mercury (particularly effective), lead, arsenic, cadmium, and copper.
- Administration: Intravenous or oral.
- Key applications: Mercury toxicity (considered by many practitioners to be the most effective mercury chelator), mixed metal exposures.
- Special consideration: DMPS mobilization testing (measuring urinary metal excretion after a DMPS dose) is used diagnostically to assess body metal burden.
Other Chelating Agents
- Deferoxamine: Specific for iron overload (hemochromatosis, transfusion-related iron accumulation).
- D-Penicillamine: Used for copper overload (Wilson’s disease) and occasionally for lead.
- Alpha-lipoic acid: A mild, naturally occurring chelator that crosses the blood-brain barrier — used cautiously as an adjunct for mercury mobilization.
Which Metals and Why They Matter
Chronic exposure to toxic metals is far more common than most people realize. Sources include industrial pollution, contaminated food and water, dental materials, occupational exposure, and consumer products.
Mercury
Sources include dental amalgam fillings, certain fish (tuna, swordfish), industrial pollution, and some traditional medicines. Mercury is a potent neurotoxin and immune disruptor. It accumulates in the brain, kidneys, and thyroid, and is associated with cognitive decline, chronic fatigue, mood disorders, and immune dysfunction.
Lead
Despite regulatory progress, lead exposure remains significant through old paint, contaminated soil, certain ceramics and cosmetics, and industrial sources. Lead affects virtually every organ system, with particular impact on the nervous system, kidneys, and cardiovascular system.
Cadmium
Primarily from cigarette smoke, contaminated food (particularly rice from polluted areas), and industrial exposure. Cadmium accumulates in the kidneys and is associated with renal damage, osteoporosis, and cancer risk.
Arsenic
Found in contaminated groundwater (a major global health issue), rice, pressure-treated wood, and certain pesticides. Chronic arsenic exposure increases cancer risk and damages the cardiovascular, nervous, and gastrointestinal systems.
Aluminum
Sources include antacids, antiperspirants, cookware, food additives, and contaminated water. Aluminum accumulation has been linked to neurological dysfunction and is an area of active research in neurodegenerative disease.
Testing First: Our Diagnostic Approach
At St. George Hospital, we never administer chelation therapy without first establishing a clear picture of the patient’s metal burden. Our diagnostic protocol includes:
Baseline Testing
- Blood metals panel: Measures circulating levels of common toxic metals.
- Urine metals (unprovoked): Baseline urinary excretion of metals.
- Hair mineral analysis: Reflects chronic exposure patterns over the preceding 2–3 months.
Provocation (Challenge) Testing
- DMPS challenge test: A carefully dosed oral or IV DMPS administration followed by timed urine collection. The metals excreted after provocation reflect the body’s stored burden, not just recent exposure.
- Interpretation: Results are compared to reference ranges and correlated with clinical symptoms and history.
Organ Function Assessment
- Kidney function: Essential before and during chelation — the kidneys are the primary excretion route for chelated metals.
- Liver function: The liver plays a key role in metal metabolism and detoxification.
- Essential mineral levels: Chelation can inadvertently deplete beneficial minerals (zinc, copper, magnesium). Baseline levels guide replacement strategies.
The Treatment Protocol
Our chelation protocols are individualized based on the metals identified, their levels, the patient’s clinical condition, and their treatment goals.
Typical IV Chelation Session
- Pre-treatment hydration: Adequate hydration protects the kidneys and supports metal excretion.
- Infusion: The chelating agent (e.g., EDTA or DMPS) is administered IV over 1–3 hours in a comfortable clinical setting.
- Mineral replacement: Concurrent or post-infusion supplementation with essential minerals to prevent depletion.
- Monitoring: Vital signs are checked throughout. Post-treatment blood and urine specimens may be collected.
Treatment Frequency and Duration
- Acute toxicity: More frequent sessions (2–3 per week) until levels normalize.
- Chronic burden: Typically 1–2 sessions per week for 10–30 sessions, depending on metal levels and response.
- Maintenance: Some patients benefit from periodic maintenance chelation (monthly or quarterly) to prevent re-accumulation.
Safety and Side Effects
Chelation therapy, when administered by experienced physicians with proper monitoring, has an excellent safety record spanning decades of clinical use.
Common Side Effects
- Mild burning or discomfort at the IV site
- Temporary fatigue following treatment (as the body processes mobilized metals)
- Mild headache
- Transient drop in blood pressure during infusion
Manageable Risks
- Essential mineral depletion: Prevented through concurrent mineral supplementation and regular monitoring.
- Renal stress: Minimized through proper hydration, dose adjustment, and renal function monitoring.
- Redistribution: Improperly dosed chelation can mobilize metals without adequate excretion, potentially redistributing them to sensitive tissues. This underscores the importance of experienced supervision.
Contraindications
- Severe renal insufficiency
- Pregnancy
- Active severe dehydration
- Certain cardiac arrhythmias (for EDTA specifically)
Who Benefits from Chelation Therapy?
In our clinical experience at St. George Hospital, chelation therapy benefits patients in several categories:
- Documented heavy metal toxicity: Patients with elevated metal levels confirmed through testing.
- Chronic fatigue and unexplained illness: When comprehensive evaluation reveals significant metal burden as a contributing factor.
- Cancer patients: Heavy metals can suppress immune function and promote oxidative stress. Reducing metal burden supports the body’s ability to fight cancer. This is part of our comprehensive integrative oncology approach.
- Lyme disease patients: Metal burden can impair immune function and treatment response. Chelation as part of a comprehensive Lyme protocol may improve outcomes.
- Cardiovascular patients: Based on the TACT trial evidence showing cardiovascular event reduction.
- Neurological patients: Those with cognitive decline, neuropathy, or other neurological symptoms potentially linked to metal toxicity.
- Autoimmune conditions: Mercury and other metals have been implicated as environmental triggers for autoimmune disease.
Chelation as Part of a Comprehensive Detoxification Strategy
At St. George Hospital, chelation is one component of our broader detoxification philosophy. We combine it with:
- Ozone therapy: Supports oxygen delivery and antioxidant defense systems during metal mobilization.
- Liver support: Specific nutrients (glutathione, milk thistle, alpha-lipoic acid) to enhance hepatic detoxification pathways.
- Gut health optimization: Binding agents and probiotics to prevent reabsorption of excreted metals through the gut.
- Infrared sauna therapy: Supporting metal excretion through sweat.
- Nutritional optimization: A nutrient-dense, anti-inflammatory diet supports all detoxification processes.
Frequently Asked Questions
How do I know if I have heavy metal toxicity?
Symptoms of chronic metal burden are often nonspecific — fatigue, brain fog, headaches, mood changes, immune dysfunction, and unexplained pain. Testing is the only way to confirm metal burden. At St. George Hospital, we use a combination of blood, urine, and provocation testing to provide a clear picture. Our medical team interprets results in the context of your clinical history and symptoms.
Is chelation therapy scientifically proven?
For acute heavy metal poisoning, chelation therapy is universally accepted standard of care. For chronic low-level metal exposure and cardiovascular application, the evidence is growing — the NIH-funded TACT trial provided significant supporting data. For other applications, clinical experience is substantial, though large-scale randomized trials are limited. We present the evidence honestly and help patients make informed decisions (Lamas et al., 2014).
Can I do chelation therapy at home?
Oral chelators (DMSA, certain forms of DMPS) can be taken at home under physician supervision. However, IV chelation should always be administered in a clinical setting with monitoring. Unsupervised chelation carries risks of mineral depletion and improper metal mobilization. We provide detailed home protocols for patients who qualify, with ongoing remote monitoring.
How many sessions will I need?
This depends on the type and degree of metal burden, your kidney function, and your clinical response. Typical courses range from 10 to 30 sessions for IV chelation. Dr. Julian Douwes develops a personalized treatment plan based on your diagnostic results and adjusts it based on follow-up testing.
Will chelation remove my dental amalgam mercury?
Chelation removes mercury that has already accumulated in body tissues. If dental amalgams are still in place, they will continue to release mercury vapor. We typically recommend safe amalgam removal (by a trained biological dentist using proper protective protocols) before or concurrent with chelation for optimal results.
Contact Us
If you suspect heavy metal burden may be contributing to your health concerns, our team at St. George Hospital can provide comprehensive testing and, when indicated, individualized chelation therapy.
St. George Hospital (Klinik St. Georg)
Rosenheimer Str. 6–8, 83043 Bad Aibling, Germany
Phone: +49 (0)8061 398-0
Email: info@clinicum-stgeorg.de
Request a consultation — We treat patients from over 90 countries.
]]>